Xtl Biopharma ADR XTLB

$1.60 -0.04 (-2.44%)

Valuation

Market cap
3,927,000
Revenue TTM
$0
Net income TTM
$-6,970,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
-1.08

Trading

Volume
5,900
Avg volume
7,544
Day's range
$1.54 – $1.73
Shares out
2,366,000
Stochastic %K
21%
Beta
1.52
Analysts
—
Price target
$6.00

Price

Company profile

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. The company's lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the resea...

Show more

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. The company's lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Herzliya, Israel.

Industry
Biotechnology
Sector
Healthcare
Phone
972 5 4228 8897
Website
https://www.xtlbio.com
Address
85 Medinat Hayehudim St., Herzliya, Israel

Latest news

Stocktwits

Rayvio_News_Filter Oct 29, 8:03 PM
$BHVN · $XTLB 🤝 Biohaven Ltd. entered an exclusive global license agreement with SK Biopharmaceuticals Co., Ltd. for its Kv7 ion channel platform, including opakalim, providing $400 million in near-term cash consideration to Biohaven. Curated for market relevance
0 replies
NVDAMillionaire Sep 22, 1:33 PM
$XTLB Excellent article that nails exactly where XTLB stands right now. So if you want to update your XTLB knowledge or get acquainted with XTLB, this is a must read. https://everyticker.com/quote/XTLB/analysis/xtlb-s-hail-mary-a-nasdaq-listed-bet-on-psychedelic-therapeutics-amid-financial-distress-nasdaq-xtlb
0 replies
vcaelum Aug 18, 5:06 PM
$XTLB trying my luck in 3.4 hard SL 2.9, bit chasing but I'll take it
0 replies
Guru1933 Jul 17, 10:42 AM
$PHOE $AEHR Come over to $HUBC & $XTLB both are ready to explode for quick profits! 🔥🔥🔥🔥
1 replies
Guru1933 Jul 17, 10:42 AM
$XDNA.X $AEHR Come over to $HUBC & $XTLB both are ready to explode for quick profits!
0 replies
Guru1933 Jul 17, 10:41 AM
$SPCX $AEHR Come over to $HUBC & $XTLB both are ready to explode for quick profits! 🚀🚀🚀🚀
0 replies
Guru1933 Jul 17, 10:40 AM
$AEHR Come over to $HUBC & $XTLB both are ready to explode for quick profits! 🔥🔥🔥🔥
0 replies
Guru1933 Jul 16, 1:23 PM
$XTLB 🔥🔥🔥🔥
0 replies